The decision follows a June 5 meeting of the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC). The committee reviewed data on virus variants, vaccine effectiveness ...
FDA committee is meeting to make plans for updated ... FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) — a 16-member committee that decides on vaccine composition ...